NFKB1 and intermediate coronary syndrome: Similar to the results of this study, the intervention of clopidogrel in unstable angina pectoris can significantly improve the blood lipid level, reduce the expression of TNF-α, IL-1, and IL-6, and downregulate the activity of NF-κB. So it has definite efficacy and good safety and is worthy of clinical promotion [26].